Savara Inc.

Savara Inc.

Pharmaceutical Manufacturing

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases.

About us

Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com. More information on the Phase 3 IMPALA-2 clinical trial in aPAP can be found at www.impala2.com

Website
http://www.savarapharma.com
Industry
Pharmaceutical Manufacturing
Company size
11-50 employees
Headquarters
United States
Type
Public Company
Founded
2007
Specialties
biotech, biopharma, pulmonary, dry-powder, dpi, therapeutics, lung, respiratory, aerosol, inhaler, drug delivery, and rare disease

Locations

Employees at Savara Inc.

Updates

Similar pages

Browse jobs

Funding

Savara Inc. 15 total rounds

Last Round

Post IPO equity

US$ 100.0M

See more info on crunchbase